AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Hydrochlorothiazide/Losartan Potassium in Ghana
5 products registered with FDA Ghana — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ZATANAL PLUS TABLETS (Each tablet contains Hydrochlorothiazide/Losartan Potassium 50mg/12.5mg) | UNKNOWN-2dada556 | — | active | 1 Jul 2031 |
| LOSAR-H TABLETS ( Hydrochlorothiazide/Losartan Potassium 50 mg/2.5 mg) | UNKNOWN-5826b94d | — | active | 1 Oct 2028 |
| LOSAR-H TABLETS ( Hydrochlorothiazide/Losartan Potassium 50 mg/2.5 mg) | UNKNOWN-9bc0af8d | — | active | 1 Oct 2028 |
| LOSHAL-H | UNKNOWN-ace61dd9 | — | active | 1 Jul 2027 |
| LOSHAL-H | UNKNOWN-fb4753bd | — | active | 1 Jul 2027 |
Hydrochlorothiazide/Losartan Potassium — FDA Ghana Registration Details
FDA Ghana (Ghana) has 5 registered products containing Hydrochlorothiazide/Losartan Potassium, of which 5 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Hydrochlorothiazide/Losartan Potassium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.